AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) saw an upside of 2.57% to $1.14 after adding $0.03 on Tuesday. The 5-day average trading volume is 959,852 shares of the company’s common stock. It has gained $1.3000 in the past week and touched a new high 5 times within the past 5 days. An average of 351,583 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 211,423.
ACRX’s 1-month performance is 12.72% or $0.1000 on its low of $0.7500 reached on 08/15/23. The company’s shares have touched a 52-week low of $0.55 and high of $7.17, with the stock’s rally to the 52-week high happening on 01/13/23. YTD, ACRX has lost -49.62% or -$1.1400 and has reached a new high 3 times. However, the current price is down -84.12% from the 52-week high price.
Valuation Metrics
ACRX stock has a beta of 0.20. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 17.95 while the price-to-book (PB) in the most recent quarter is 1.20.
In terms of profitability, the gross margin trailing 12 months is 8.00%. The trailing 12-month EBITDA margin is -1696.10%. The firm’s gross profit as reported stood at -$0.82 million against revenue of $1.77 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income grew 1716.93% to -$4.37 million, while revenue of -$8.15 million was -86.5% off the previous quarter. Analysts expected ACRX to announce -$0.53 per share in earnings in its latest quarter, but it posted -$0.4, representing a 24.50% surprise. EBITDA for the quarter stood at more than -$3.92 million. Shareholders hold equity totaling $16.34 million.
Let’s look briefly at AcelRx Pharmaceuticals Inc. (ACRX) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 21 August was 69.94% to suggest the stock is trending Neutral, with historical volatility in this time period at 179.75%.
The stock’s 5-day moving average is $0.9487, reflecting a +46.41% or $0.3550 change from its current price. ACRX is currently trading +9.80% above its 20-day SMA, +55.56% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -9.68% and SMA200 by-50.66%.
Stochastic %K and %D was 68.52% and 50.61% and the average true range (ATR) pointed at 0.1157. The RSI (14) points at 61.81%, while the 14-day stochastic is at 67.27% with the period’s ATR at 0.1048. The stock’s 9-day MACD Oscillator is pointing at 0.1387 and 0.1102 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX), Credit Suisse downgraded it to an Underperform rating. They previously had a Neutral rating on the stock. Analysts offering their rating for ACRX stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate ACRX as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 1 have offered a “buy” rating.
What is ACRX’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $8.00 and a high of $8.00, with their median price target at $8.00. Looking at these predictions, the average price target given by analysts is for AcelRx Pharmaceuticals Inc. (ACRX) stock is $8.00.
